cefonicid has been researched along with cefamandole in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 83 (93.26) | 18.7374 |
1990's | 4 (4.49) | 18.2507 |
2000's | 2 (2.25) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barry, AL; Doern, GV; Ferraro, MJ; Jorgensen, JH; Murray, PR | 1 |
Garcia, S; Gatell, JM; Lozano, ML; Ramon, R; Sanmiguel, JG; Soriano, E | 1 |
Aaron, BL; Gooch, W; Labriola, AM; Salzman, C; Tuazon, CU | 1 |
Amarshi, N; Craft, RB; Gelfand, MS; Harrington, OB; Martin, F; Owen, EW; Schoettle, P; Simmons, BP | 1 |
Cazzola, M; D'Amato, G; Lobefalo, G; Lupis, F; Martucci, P; Vanacore, L | 1 |
Besa, G; Broccali, G; Furlan, G; Gusmitta, A | 1 |
Ackerman, BH; Kearns, GL; Manning, JT; Monson, TP; Trang, JM; Underwood, FL | 1 |
Arnau, JM; Cano, M; Colomé, E; Jodar, R; Laporte, JR; Montoro, B; Rodríguez, C | 1 |
Naden, MG; Watt, B | 1 |
D'Elia, R; Furlanut, M; Pasinelli, F; Riva, E | 1 |
Glatt, AE | 1 |
Cozens, RM; Suter, J; Tomasz, A; Tosch, W; Tuomanen, E; Zak, O | 1 |
Chanal, M; Cluzel, M; Cluzel, R; Joly, B; Sirot, D; Sirot, J | 1 |
Bahado-Singh, R; Bogh, P; Briggs, GG; Garite, TJ; Lange, S; Moore, BR | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Glazier, HS | 1 |
Dudley, MN; Nightingale, CH; Quintiliani, R; Shyu, WC | 2 |
Prichard, JG | 1 |
Ackerman, BH; Harrison, BH; Manning, JT; Nelson, CL; Pearce, CE; Trang, JM | 1 |
Benirschke, SK; Brumback, R; Burgess, A; Caplan, ES; Dellinger, EP; Droppert, BM; Hoyt, N; Poka, A; Weaver, LD; Wertz, MJ | 1 |
Cohen, MS; Weber, DJ | 1 |
Davis, WA; Kane, JG | 1 |
Bloom, JC; Morgan, DG; Thiem, PA | 1 |
Azanza, JR; Cuena, R; Honorato, J; Rubio, A | 1 |
Fink, S; Karp, W; Robertson, A | 1 |
Montany, PF; Scher, KS; Scott-Conner, CE | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 1 |
Hajj, SN; Ismail, MA; Mercer, LJ; Murphy, HJ | 1 |
Guay, DR; Heim-Duthoy, KL; Matzke, GR; Peltier, GL | 1 |
Benrubi, G; Hartert, RA; Nuss, RC; Thompson, RJ | 1 |
Concia, E; Cruciani, M; Savio, S | 1 |
Ginzler, F; Jain, AK; LaCorte, W; McMahon, FG; Ryan, JR | 1 |
Markowitz, A; Nadworny, HA | 1 |
Harvengt, C | 1 |
Bergman, MM; Gleckman, RA | 1 |
Balocchini, E; Bordonaro, P; Mazzei, T; Mini, E; Ninu, B; Periti, P; Reali, EF | 2 |
Brogden, RN; Saltiel, E | 1 |
Cozens, R; Tomasz, A; Tosch, W; Tuomanen, E; Zak, O | 1 |
Curry, J; Deterding, J; Gal, P; Lane, T; Morse, GD; Nairn, DK | 1 |
Soper, DE; Yarwood, RL | 1 |
Concia, E; Cruciani, M; Passarella, E; Soncini, R | 1 |
Bloom, JC; Deldar, A; Lewis, HB; Sellers, TS | 1 |
Bloom, JC; Deldar, A; Lewis, HB; Morgan, DG; Sellers, TS | 1 |
Uri, JV | 1 |
Calio, AJ; Cunha, BA; Cusumano, S; Tjioe, DY; Ullman, RF | 1 |
Duff, P; Read, JA; Robertson, AW | 1 |
Biage, GI; Bolognini, G | 1 |
Johnson, CM; Kang, YJ; Manson, JM; Zolna, LE | 1 |
Higbee, M; Ramsey, R; Swenson, E | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Conte, JE; Phelps, RT | 1 |
Madura, AJ; Tse, CS; Vera, FH | 1 |
Weinstein, MP | 1 |
Garabedian-Ruffalo, SM; Tuazon, CU | 1 |
Fillastre, JP; Fourtillan, JB; Humbert, G; Lefevre, MA; Leroy, A; Ramis, N; Reumont, G | 1 |
Figini, G; Germiniani, R; Mastropasqua, E; Mauri, J; Rosina, M | 1 |
Deamer, RL; Prichard, JG; Sauerwein, M | 1 |
Brumfitt, W; Hamilton-Miller, JM; Patel, R | 1 |
Polk, RE; Tartaglione, TA | 1 |
Blue, D; Rapp, RP | 1 |
di Nola, F | 1 |
Brendel, E; Meineke, I; Zschunke, M | 1 |
Maderich, AB; Polli, GP; Ravin, LJ; Wong, WW | 1 |
Evrard, HM; Lentnek, AL; Phillips, SW; Sohn, CA; Wikler, MA | 1 |
Brogard, JM; Comte, F | 1 |
Bayer, AS; Kim, KS; Morrison, JO | 1 |
Gruninger, RP; Khan, MY; Siddiqui, Y | 1 |
Drezner, AD; Dudley, MN; Low, HB; Nightingale, CH; Quintiliani, R | 1 |
Gremillion, DH; Vandenbout, E; Winn, RE | 1 |
Actor, P; Newman, DJ; Rake, JB | 1 |
Berg, SW; Harrison, WO; Kerbs, SB; Lancaster, DJ; Sanchez, PL | 1 |
Harrod, LG; Raff, MJ; Summersgill, JT | 1 |
Boscia, JA; Kaye, D; Krieger, RE; Levison, ME; McNamee, W; Pontzer, RE | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Axelrod, JL; Kochman, RS | 1 |
Connor, DJ; Norman, JC; Sterling, RP | 1 |
Blair, AD; Cutler, RE; Forland, SC; Jacob, L; Maxwell, BM | 1 |
Actor, P; Grappel, SF; Lewis, HB; Morgan, DG; Phillips, L | 1 |
Connor, DJ; Cooley, DA; Norman, JC; Sterling, RP | 1 |
Actor, P; Bowie, BA; Mehta, RJ; Nash, CH; Newman, DJ | 1 |
Awe, RJ; Greenberg, SB; Martin, RR; Niefield, SL; Wallace, RJ; Waters, B; Waters, S; Wiss, K | 1 |
Barriere, SL; Conte, JE; Gambertoglio, JG; Hatheway, GJ; Lin, ET | 1 |
Actor, P; Alexander, F; Dubb, J; Ehrlich, S; Familiar, R; Pitkin, D; Stote, R | 1 |
Actor, P; Grappel, SF; Guarini, JR; Weisbach, JA | 1 |
5 review(s) available for cefonicid and cefamandole
Article | Year |
---|---|
Second-generation cephalosporins.
Topics: Bacterial Infections; Bacteroides Infections; Cefamandole; Cefazolin; Cefonicid; Cefoxitin; Cefuroxime; Cephalosporins; Gonorrhea; Haemophilus Infections; Humans; Respiratory Tract Infections; Structure-Activity Relationship | 1986 |
The role of conventional pathology and toxicology in evaluating the immunotoxic potential of xenobiotics.
Topics: Animals; Auranofin; Cefamandole; Cefonicid; Humans; Immune System; Toxicology | 1987 |
Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Topics: Bacterial Infections; Cefamandole; Cefonicid; Humans | 1986 |
Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Topics: Bacteria; Bacterial Infections; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Costs and Cost Analysis; Humans; Kinetics | 1985 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
16 trial(s) available for cefonicid and cefamandole
Article | Year |
---|---|
Prophylaxis against infection. Single-dose cefonicid compared with multiple-dose cefamandole.
Topics: Aged; Cefamandole; Cefonicid; Drug Administration Schedule; Female; Humans; Male; Metals; Middle Aged; Orthopedic Fixation Devices; Orthopedics; Premedication; Prospective Studies; Surgical Wound Infection | 1991 |
Serum and atrial tissue concentrations of cefonicid and cefamandole in patients undergoing coronary artery bypass graft surgery.
Topics: Cefamandole; Cefonicid; Coronary Artery Bypass; Double-Blind Method; Heart Atria; Humans; Myocardium | 1990 |
Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: a prospective study.
Topics: Cardiac Surgical Procedures; Cefamandole; Cefonicid; Double-Blind Method; Endocarditis, Bacterial; Enterobacteriaceae Infections; Heart Valve Prosthesis; Humans; Premedication; Prospective Studies; Random Allocation; Staphylococcal Infections; Surgical Wound Infection | 1990 |
Duration of preventive antibiotic administration for open extremity fractures.
Topics: Adult; Bacterial Infections; Cefamandole; Cefonicid; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Extremities; Female; Fractures, Open; Humans; Male; Prospective Studies; Random Allocation | 1988 |
Outpatient antibiotic therapy for osteomyelitis.
Topics: Cefamandole; Cefonicid; Clinical Trials as Topic; Humans; Osteomyelitis; Outpatients | 1987 |
Antimicrobial prophylaxis for arthroplasty: a comparative study of cefonicid and cefazolin.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty; Cefamandole; Cefazolin; Cefonicid; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Random Allocation; Staphylococcal Infections | 1987 |
A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
Topics: Bacteria; Cefamandole; Cefonicid; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Random Allocation; Respiratory Tract Infections | 1987 |
A comparison of cefonicid and cefoxitin for preventing infections after vaginal hysterectomy.
Topics: Adult; Cefamandole; Cefonicid; Cefoxitin; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Maternal Age; Pregnancy, High-Risk; Surgical Wound Infection; Vagina | 1988 |
Cefonicid vs. cefoxitin for cesarean section prophylaxis.
Topics: Adult; Age Factors; Cefamandole; Cefonicid; Cefoxitin; Cesarean Section; Endometritis; Female; Humans; Pregnancy; Prospective Studies; Random Allocation; Risk Factors; Socioeconomic Factors | 1987 |
Absence of disulfiram-type reactions to single and multiple doses of cefonicid: a placebo-controlled study.
Topics: Acetaldehyde; Adult; Cefamandole; Cefonicid; Drug Interactions; Ethanol; Humans; Male | 1987 |
Single-dose antibiotic prophylaxis in women undergoing vaginal hysterectomy.
Topics: Adult; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Infections; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Risk | 1987 |
Single-dose cefazolin versus cefonicid for antibiotic prophylaxis in cesarean delivery.
Topics: Bacterial Infections; Cefamandole; Cefazolin; Cefonicid; Cesarean Section; Double-Blind Method; Endometritis; Female; Humans; Injections, Intravenous; Pregnancy; Prospective Studies; Random Allocation | 1987 |
Clinical trial of cefonicid for treatment of skin infections.
Topics: Adult; Cefamandole; Cefonicid; Cellulitis; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Skin Diseases, Infectious | 1983 |
Cefonicid sodium (Monocid).
Topics: Bacteria; Bacterial Infections; Cefamandole; Cefonicid; Clinical Trials as Topic; Humans; Kinetics; Microbial Sensitivity Tests | 1984 |
Single-dose cefonicid therapy for urinary tract infections.
Topics: Adult; Amoxicillin; Bacteria; Cefamandole; Cefonicid; Cephalosporins; Female; Humans; Middle Aged; Penicillin Resistance; Urinary Tract Infections | 1983 |
Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
Topics: Adult; Cefamandole; Cefonicid; Cephalosporins; Clinical Trials as Topic; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Pneumococcal Infections; Pneumonia; Random Allocation | 1982 |
68 other study(ies) available for cefonicid and cefamandole
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Topics: Ampicillin; Cefaclor; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards | 1992 |
The effects of cefonicid on the pharmacokinetics of a once-a-day theophylline formulation.
Topics: Adult; Aged; Cefamandole; Cefonicid; Delayed-Action Preparations; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Theophylline | 1989 |
Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
Topics: Adult; Aged; Bronchi; Cefamandole; Cefonicid; Female; Humans; Lung; Male; Middle Aged; Pleura | 1989 |
Effect of age and renal function on cefonicid pharmacokinetics.
Topics: Adult; Aged; Aged, 80 and over; Aging; Cefamandole; Cefonicid; Creatinine; Humans; Kidney Diseases; Male | 1989 |
Evaluation of cefonicid use in a general hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefamandole; Cefonicid; Costs and Cost Analysis; Drug Utilization; Female; Follow-Up Studies; Hospitals, General; Humans; Male; Middle Aged; Spain | 1989 |
The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
Topics: Bacteroides fragilis; Cefamandole; Cefonicid; Cefotetan; Ceftriaxone; Clindamycin; Clostridium perfringens; Microbial Sensitivity Tests; Peptostreptococcus | 1988 |
Pharmacokinetics of cefonicid in children.
Topics: Absorption; Cefamandole; Cefonicid; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Male; Metabolic Clearance Rate; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat.
Topics: Anti-Bacterial Agents; Bacteria; Blood Specimen Collection; Cefamandole; Cefonicid; Ceftriaxone; Cephamycins; Culture Media; Enterobacteriaceae; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests | 1986 |
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
Topics: Bacteria; Cefamandole; Cefonicid; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1986 |
Cost-effectiveness of cefonicid sodium versus cefoxitin sodium for the prevention of postoperative infections after nonelective cesarean section.
Topics: Adult; Bacterial Infections; Cefamandole; Cefonicid; Cefoxitin; Cesarean Section; Cost-Benefit Analysis; Female; Humans; Postoperative Complications; Pregnancy | 1987 |
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins | 1987 |
Cost-effectiveness of cefonicid versus cefoxitin prophylaxis for cesarean section.
Topics: Cefamandole; Cefonicid; Cefoxitin; Cesarean Section; Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Pregnancy; Premedication | 1987 |
Effect of protein binding on drug penetration into blister fluid.
Topics: Adult; Blister; Blood Proteins; Cefamandole; Cefonicid; Cefotaxime; Ceftizoxime; Extracellular Space; Female; Humans; Male; Protein Binding; Tissue Distribution | 1988 |
Role of long-acting cephalosporins in ambulatory therapy.
Topics: Ambulatory Care; Cefamandole; Cefonicid; Ceftriaxone; Costs and Cost Analysis; Humans; Osteomyelitis; Pneumonia; Pyelonephritis; Skin Diseases, Infectious | 1988 |
Disposition of cefonicid in orthopedic surgery patients.
Topics: Adult; Aged; Blood Proteins; Cefamandole; Cefonicid; Female; Hip Prosthesis; Humans; Male; Middle Aged; Protein Binding | 1988 |
Effect of cephalosporins on bilirubin-albumin binding.
Topics: Bilirubin; Cefamandole; Cefonicid; Cephalosporins; Fetal Blood; Humans; Osmolar Concentration; Oxidation-Reduction; Serum Albumin | 1988 |
Effect of cephalosporins on fascial healing after celiotomy.
Topics: Animals; Cefamandole; Cefazolin; Cefonicid; Drug Administration Schedule; Fasciotomy; Female; Laparotomy; Premedication; Rats; Rats, Inbred Strains; Surgical Wound Dehiscence; Time Factors; Wound Healing | 1988 |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes | 1988 |
Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
Topics: Adult; Cefamandole; Cefonicid; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Skin Diseases, Infectious | 1988 |
Cefonicid concentration in lung tissue after intramuscular administration.
Topics: Cefamandole; Cefonicid; Humans; Injections, Intramuscular; Lung; Male; Middle Aged | 1987 |
Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefamandole; Cefonicid; Child; Female; Home Care Services; Home Nursing; Humans; Injections, Intramuscular; Male; Middle Aged; Retrospective Studies; Self Administration | 1987 |
Drugs recently released in Belgium: aztreonam, cefotetan, cefonicid.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefotetan; Cephamycins; Humans | 1986 |
Newer antibiotics: their place in geriatric care. Part I.
Topics: Bacterial Infections; Cefamandole; Cefazolin; Cefonicid; Cefotetan; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Geriatrics; Humans | 1986 |
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Topics: Bacteria; Blister; Cefamandole; Cefonicid; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged | 1987 |
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefamandole; Cefonicid; Cell Wall; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases | 1986 |
Peritoneal transport of cefonicid.
Topics: Cefamandole; Cefonicid; Humans; Kidney Failure, Chronic; Kinetics; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Topics: Bacteria; Bacterial Infections; Cefamandole; Cefonicid; Drug Resistance, Microbial; Female; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Skin Absorption | 1987 |
Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
Topics: Adult; Blister; Body Fluids; Cefamandole; Cefonicid; Half-Life; Humans; Kinetics; Male | 1987 |
The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.
Topics: Anemia; Animals; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Male; Neutropenia; Thrombocytopenia | 1987 |
The hematopathology of cefonicid- and cefazedone-induced blood dyscrasias in the dog.
Topics: Animals; Bone Marrow; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Disease Models, Animal; Dogs; Hematopoiesis; Liver; Neutrophils; Paraproteinemias | 1987 |
A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
Topics: Animals; Biological Availability; Blood Proteins; Cefamandole; Cefazolin; Cefonicid; Cephaloridine; Cephalothin; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests | 1987 |
Haemophilus parainfluenzae endocarditis.
Topics: Aged; Aged, 80 and over; Cefamandole; Cefonicid; Endocarditis, Bacterial; Female; Haemophilus Infections; Humans; Microbial Sensitivity Tests | 1987 |
[Efficacy and tolerance of cefonicid in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Cefamandole; Cefonicid; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1987 |
Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.
Topics: Age Factors; Animals; Cefamandole; Cefonicid; Cephalothin; Chemical Phenomena; Chemistry; Copulation; Female; Fertility; Injections, Subcutaneous; Male; Moxalactam; Pregnancy; Random Allocation; Rats; Rats, Inbred Strains; Seminiferous Tubules; Sexual Maturation; Sperm Count; Testis | 1987 |
Cefonicid-induced seizure.
Topics: Cefamandole; Cefonicid; Female; Humans; Seizures; Syncope | 1987 |
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.
Topics: Cefamandole; Cefonicid; Culture Media; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Temperature; Time Factors | 1986 |
Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
Topics: Adult; Aged; Cefamandole; Cefonicid; Creatinine; Female; Half-Life; Humans; Kidney Diseases; Kidney Function Tests; Kinetics; Male; Middle Aged | 1986 |
Suspected cefonicid-induced seizure.
Topics: Adolescent; Cefamandole; Cefonicid; Female; Humans; Seizures | 1986 |
Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.
Topics: Cefamandole; Cefazolin; Cefonicid; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus | 1986 |
Cefonicid cost analysis compared with conventional therapy in serious infections.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefamandole; Cefonicid; Costs and Cost Analysis; Humans; Middle Aged | 1986 |
Pharmacokinetics of cefonicid in uraemic patients.
Topics: Adult; Aged; Cefamandole; Cefonicid; Creatinine; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Uremia | 1986 |
[In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
Topics: Bacteria; Cefamandole; Cefonicid; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1986 |
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
Topics: Adult; Blood Proteins; Cefamandole; Cefonicid; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Models, Biological; Protein Binding | 1986 |
Use of long half-life parenteral cephalosporins in ambulatory practice.
Topics: Ambulatory Care; Bacterial Infections; Cefamandole; Cefonicid; Ceftriaxone; Cellulitis; Cephalosporins; Gonorrhea; Half-Life; Humans; Injections, Intramuscular; Osteomyelitis; Pyelonephritis; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections | 1987 |
Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
Topics: Cefamandole; Cefonicid; Cephalosporins; Drug Interactions; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1986 |
The role of the extended half-life second-generation cephalosporins in surgical prophylaxis.
Topics: Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Half-Life; Humans; Premedication; Surgical Wound Infection | 1985 |
[Update on antibiotic therapy. 30) Cefonicid].
Topics: Biological Transport; Cefamandole; Cefonicid; Drug Stability; Drug Therapy; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kidney Diseases; Kinetics; Respiratory Tract Infections; Tissue Distribution; Urinary Tract Infections | 1985 |
High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
Topics: Cefamandole; Cefonicid; Chromatography, High Pressure Liquid; Humans; Kinetics | 1985 |
Stability of cefonicid sodium in infusion fluids.
Topics: Cefamandole; Cefonicid; Chromatography, High Pressure Liquid; Drug Stability; Freezing; Infusions, Parenteral; Solutions; Time Factors | 1985 |
Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
Topics: Cefamandole; Cefonicid; Drug Evaluation; Female; Humans; Male; Staphylococcal Infections | 1985 |
Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
Topics: Cefamandole; Cefonicid; Cefotaxime; Ceftizoxime; Cephalosporins; Dose-Response Relationship, Drug; Penicillin G; Penicillin Resistance; Streptococcus agalactiae | 1982 |
Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefonicid; Cefotaxime; Cefotiam; Ceftriaxone; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1982 |
Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
Topics: Aged; Cefamandole; Cefazolin; Cefonicid; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Myocardium; Pericardium; Premedication | 1984 |
Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
Topics: Bacterial Proteins; Carbon Radioisotopes; Carboxypeptidases; Carrier Proteins; Cefamandole; Cefonicid; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases | 1984 |
Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
Topics: Adolescent; Adult; Cefamandole; Cefonicid; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Urethritis | 1984 |
Azlocillin and cefonicid penetration into bone enhanced by probenecid.
Topics: Animals; Azlocillin; Bone and Bones; Cefamandole; Cefonicid; Half-Life; Probenecid; Rabbits | 1984 |
Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
Topics: Bacteria; beta-Lactamase Inhibitors; Cefamandole; Cefonicid; Cefoxitin; Cell Membrane Permeability; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Quality Control; Regression Analysis | 1983 |
Cefonicid concentrations in human aqueous humor.
Topics: Aqueous Humor; Bacterial Infections; Cefamandole; Cefonicid; Endophthalmitis; Eye Proteins; Humans; Protein Binding | 1984 |
Plasma and myocardial levels of cefonicid during open-heart surgery.
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cefamandole; Cefonicid; Cephalosporins; Humans; Middle Aged; Myocardium; Premedication; Surgical Wound Infection | 1983 |
Cefonicid kinetics in subjects with normal and impaired renal function.
Topics: Cefamandole; Cefonicid; Creatinine; Humans; Kidney Diseases; Kinetics; Metabolic Clearance Rate; Renal Dialysis | 1984 |
Prophylactic activity of cephalosporins in a mouse model of surgical wound infection.
Topics: Animals; Cefamandole; Cefonicid; Cephalosporins; Disease Models, Animal; Leukocyte Count; Mice; Surgical Wound Infection | 1983 |
Cefonicid concentrations in serum and atrial tissue during open-heart surgery.
Topics: Aged; Cardiac Surgical Procedures; Cefamandole; Cefonicid; Cephalosporins; Humans; Middle Aged; Myocardium; Premedication | 1983 |
Cefonicid: a stable beta-lactamase inhibitor.
Topics: beta-Lactamase Inhibitors; Cefamandole; Cefonicid; Cephalosporins; Cephalothin; Drug Stability; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Hydrolysis | 1981 |
Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Topics: Biological Assay; Cefamandole; Cefonicid; Cephalosporins; Half-Life; Humans; Infusions, Parenteral; Kinetics; Male | 1982 |
Kinetics and renal handling of cefonicid.
Topics: Adult; Anti-Bacterial Agents; Cefamandole; Cefonicid; Cephalosporins; Half-Life; Humans; Kidney; Kinetics; Male; Metabolic Clearance Rate; Probenecid | 1981 |
Correlation of agar-disc-diffusion tests with minimum inhibitory concentrations of cefonicid (SK&F 75073) and cephalothin.
Topics: Bacteria; Cefamandole; Cefonicid; Cephalosporins; Cephalothin; Diffusion; Microbial Sensitivity Tests | 1980 |